- Services -

Bioanalytical Services

Bioanalytical testing is used to evaluate pharmacokinetics, bioavailability, and bioequivalence of the molecule of interest in the relevant body organ, tissue, or fluid.

Research-grade and GLP testing, and ADME/PK analysis, are performed in a broad range of species, including mouse, rat, rabbit, guinea pig, dog, sheep, and non-human primate, and human.


Services We Offer

-   Development of separation methods for analytes in blood, plasma, urine, and a full range of tissues

-   High resolution detection and identification, using time-of-flight mass spectroscopy 

-   Development and Validation of methods to fully comply with OECD guidelines

-   High sample volume capacity for analysis 150,000 samples/year

-   Quantitation by triple quad mass spectroscopy fronted by ultra high pressure liquid chromotography

-   Quantitation by gas chromotography with mass spectrometry and flame ionization detection 

-   Analytical support for pre-clinical, in vitro and in vivo studies, bioequivalence, pharmacokinetic, and clinical studies

Expertise

Led by Dr. Yousif Sahly, Ph.D., Senior Director of Quality Control & Dr. Garry SouthanPh.D., Executive Vice-President of Analytical and Bioanalytical Chemistry

 

Dr. Sahly has over 25 years of experience in large and emerging pharmaceutical companies in USA and Israel, amongst, worked at Pfizer as a Director of Drug Metabolism and Pharmacokinetics (DMPK), at Merck as a Senior scientists in the DMPK department and at Teva as senior Director, Head of analytical Research and Development.

 

Dr. Southan is a nationally-renowned pharmaceutical development leader with 30 years of professional experience in Synthetic Chemistry and Biochemistry who led numerous pharmaceutical projects from invention into Phase 2 clinical trials. Former Executive Vice-President of Chemistry at Inotek Pharmaceuticals Corporation, Dr. Southan has broad experience in the pharmaceutical development process and leads senior chemists and biologists to identify, discover, in-license, and develop innovative life science technologies.

back to top